• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用钆塞酸二钠增强 3.0T MRI 对肝硬化中浸润性肝细胞癌和局灶性融合性纤维化为的鉴别诊断。

Using Gd-EOB-DTPA-enhanced 3-T MRI for the differentiation of infiltrative hepatocellular carcinoma and focal confluent fibrosis in liver cirrhosis.

机构信息

Department of Radiology, Korea University Guro Hospital, Korea University College of Medicine, Seoul 152-703, South Korea.

出版信息

Magn Reson Imaging. 2013 Sep;31(7):1137-42. doi: 10.1016/j.mri.2013.01.011. Epub 2013 May 17.

DOI:10.1016/j.mri.2013.01.011
PMID:23688409
Abstract

PURPOSE

The purpose of the study was to determine significant imaging features to differentiate between infiltrative hepatocellular carcinoma (HCC) and confluent fibrosis (CF) in liver cirrhosis using Gd-EOB-DTPA-enhanced 3-T magnetic resonance imaging.

MATERIAL AND METHODS

Nineteen infiltrative HCCs and eight CFs were included. We evaluated the difference in imaging findings and apparent diffusion coefficient (ADC) between the two entities. We compared T2-weighted image (WI) and hepatobiliary phase (HBP) in terms of the clarity of the lesion outer margin.

RESULTS

Seventeen infiltrative HCCs showed lobulated margin, while focal CFs showed either straight (n=3) or irregular margins (n=5) (P=.001). All infiltrative HCCs had intact or bulging contours, and all focal CFs showed capsular retraction (P=.001). Fourteen infiltrative HCCs and two focal CFs showed arterial enhancement (P=.035). The ADC of infiltrative HCCs was significantly lower than that of CFs (P=.001). Satellite nodules were noted in 10 infiltrative HCCs. In terms of outer margin clarity, infiltrative HCCs showed a more distinct margin on HBP than on T2-WI (P=.005), while these two sequences were not significantly different in focal CFs (P=1.000).

CONCLUSION

HBP improved the imaging characteristics of infiltrative HCC, allowing it to be distinguished from focal CF. Infiltrative HCC showed lower ADC values than focal CF. Lobular configuration, contour bulging, enhancement pattern, associated satellite nodules and portal vein thrombosis were still found to be highly suggestive MR findings for infiltrative HCC.

摘要

目的

本研究旨在利用钆塞酸二钠增强 3T 磁共振成像(MRI)确定有意义的影像学特征,以区分肝硬化中的浸润性肝细胞癌(HCC)和融合性纤维化(CF)。

材料和方法

纳入 19 例浸润性 HCC 和 8 例 CF。我们评估了两种病变的影像学表现和表观扩散系数(ADC)的差异。我们比较了 T2 加权像(WI)和肝胆期(HBP)在病变外缘清晰度方面的差异。

结果

17 例浸润性 HCC 呈分叶状边缘,而局灶性 CF 呈直线(n=3)或不规则(n=5)边缘(P=.001)。所有浸润性 HCC 均有完整或隆起的轮廓,所有局灶性 CF 均有包膜回缩(P=.001)。14 例浸润性 HCC 和 2 例局灶性 CF 呈动脉期增强(P=.035)。浸润性 HCC 的 ADC 值明显低于 CF(P=.001)。10 例浸润性 HCC 可见卫星结节。在外缘清晰度方面,浸润性 HCC 在 HBP 上的边缘比 T2-WI 更清晰(P=.005),而局灶性 CF 两种序列无明显差异(P=1.000)。

结论

HBP 改善了浸润性 HCC 的影像学特征,使其能够与局灶性 CF 区分开来。浸润性 HCC 的 ADC 值低于局灶性 CF。分叶状形态、轮廓隆起、强化模式、卫星结节和门静脉血栓形成仍然是浸润性 HCC 的高度提示性 MRI 表现。

相似文献

1
Using Gd-EOB-DTPA-enhanced 3-T MRI for the differentiation of infiltrative hepatocellular carcinoma and focal confluent fibrosis in liver cirrhosis.应用钆塞酸二钠增强 3.0T MRI 对肝硬化中浸润性肝细胞癌和局灶性融合性纤维化为的鉴别诊断。
Magn Reson Imaging. 2013 Sep;31(7):1137-42. doi: 10.1016/j.mri.2013.01.011. Epub 2013 May 17.
2
Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.钆塞酸增强肝胆期 MRI 和高 b 值扩散加权成像在慢性肝病患者中鉴别高分化肝细胞癌与良性结节
AJR Am J Roentgenol. 2011 Nov;197(5):W868-75. doi: 10.2214/AJR.10.6237.
3
Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis.钆喷替酸葡甲胺增强磁共振成像仅能预测 Child-Pugh 分级为 A 级肝硬化患者的肝癌组织学分级。
Liver Transpl. 2012 Jul;18(7):850-7. doi: 10.1002/lt.23426.
4
Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis.钆塞酸二钠增强磁共振成像和扩散加权磁共振成像检测肝细胞癌与肝硬化严重程度的关系
Acta Radiol. 2012 Oct 1;53(8):830-8. doi: 10.1258/ar.2012.120099. Epub 2012 Jul 30.
5
Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.使用钆塞酸二钠增强磁共振成像和扩散加权磁共振成像对肝炎后肝硬化患者小肝细胞癌(≤2.0 cm)诊断标准的验证
Acta Radiol. 2013 Mar 1;54(2):127-36. doi: 10.1258/ar.2012.120262. Epub 2012 Nov 12.
6
Infiltrative hepatocellular carcinoma on gadoxetic acid-enhanced and diffusion-weighted MRI at 3.0T.钆塞酸增强及扩散加权磁共振成像(3.0T)下的浸润性肝细胞癌
J Magn Reson Imaging. 2014 May;39(5):1238-45. doi: 10.1002/jmri.24265. Epub 2013 Oct 17.
7
Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA.使用钆塞酸二钠对肝细胞癌和肝硬化肝脏增强的定性和定量评估
AJR Am J Roentgenol. 2009 Oct;193(4):1053-60. doi: 10.2214/AJR.08.1946.
8
Focal lesions in the cirrhotic liver: their pivotal role in gadoxetic acid-enhanced MRI and recognition by the Western guidelines.肝硬化肝脏中的局灶性病变:其在钆塞酸增强MRI中的关键作用及西方指南中的识别方法
Dig Dis. 2014;32(6):696-704. doi: 10.1159/000368002. Epub 2014 Oct 29.
9
Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI.在钆塞酸增强肝胆期 MRI 上见到的肝脏高信号病变的鉴别诊断。
AJR Am J Roentgenol. 2011 Jul;197(1):W44-52. doi: 10.2214/AJR.10.5845.
10
Detectability of hepatocellular carcinoma by gadoxetate disodium-enhanced hepatic MRI: tumor-by-tumor analysis in explant livers.钆塞酸二钠增强肝脏 MRI 检测肝细胞癌的能力:离体肝脏的肿瘤逐个分析。
J Magn Reson Imaging. 2013 Mar;37(3):684-91. doi: 10.1002/jmri.23855. Epub 2012 Oct 10.

引用本文的文献

1
MRI findings of confluent hepatic fibrosis caused by different etiologies.不同病因所致融合性肝纤维化的磁共振成像表现
BMC Gastroenterol. 2025 Jul 10;25(1):512. doi: 10.1186/s12876-025-04101-9.
2
Multiphasic Computed Tomography Enhancement Characteristics and Utility of Delayed Phase in Infiltrative Hepatocellular Carcinoma.多期计算机断层扫描增强特征及延迟期在浸润性肝细胞癌中的应用价值
Indian J Radiol Imaging. 2024 Aug 14;35(1):67-72. doi: 10.1055/s-0044-1789191. eCollection 2025 Jan.
3
Differentiation of confluent hepatic fibrosis and infiltrative hepatocellular carcinoma on MR imaging.
磁共振成像鉴别融合性肝纤维化与浸润性肝细胞癌。
Abdom Radiol (NY). 2024 May;49(5):1479-1488. doi: 10.1007/s00261-024-04264-1. Epub 2024 Mar 29.
4
Correction of Arterial-Phase Motion Artifacts in Gadoxetic Acid-Enhanced Liver MRI Using an Innovative Unsupervised Network.使用创新的无监督网络校正钆塞酸增强肝脏MRI中的动脉期运动伪影
Bioengineering (Basel). 2023 Oct 13;10(10):1192. doi: 10.3390/bioengineering10101192.
5
[Application of Diffusion-Weighted Imaging and Hepatobiliary-Specific Contrast Agent Gd-EOB-DTPA in the Diagnosis and Differential Diagnosis of Focal Liver Lesions].扩散加权成像及肝胆特异性对比剂钆塞酸二钠在肝脏局灶性病变诊断及鉴别诊断中的应用
Sichuan Da Xue Xue Bao Yi Xue Ban. 2022 Sep;53(5):737-743. doi: 10.12182/20220960205.
6
Morphological, dynamic and functional characteristics of liver pseudolesions and benign lesions.肝脏假病灶和良性病灶的形态学、动态及功能特征
Radiol Med. 2022 Feb;127(2):129-144. doi: 10.1007/s11547-022-01449-w. Epub 2022 Jan 13.
7
Pearls and pitfalls in magnetic resonance imaging of hepatocellular carcinoma.肝细胞癌的磁共振成像的要点与陷阱。
World J Gastroenterol. 2020 May 7;26(17):2012-2029. doi: 10.3748/wjg.v26.i17.2012.
8
Infiltrative non-mass-like hepatocellular carcinoma initially presenting with isolated malignant portal vein thrombosis: A case report and review of the literature.以孤立性恶性门静脉血栓形成初发的浸润性无肿块型肝细胞癌:1例报告并文献复习
J Ultrason. 2020;20(80):e55-e60. doi: 10.15557/JoU.2020.0009. Epub 2020 Mar 31.
9
Atypical Appearance of Hepatocellular Carcinoma and Its Mimickers: How to Solve Challenging Cases Using Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging.肝细胞癌及其类似物的不典型表现:如何使用钆塞酸增强肝脏磁共振成像解决具有挑战性的病例。
Korean J Radiol. 2019 Jul;20(7):1019-1041. doi: 10.3348/kjr.2018.0636.
10
Liver Masses: What Physicians Need to Know About Ordering and Interpreting Liver Imaging.肝脏肿物:医生在开具和解读肝脏影像检查时需要了解的内容。
Curr Gastroenterol Rep. 2017 Oct 18;19(11):58. doi: 10.1007/s11894-017-0596-3.